EP2575785
ORAL DOSAGE FORMS OF BENDAMUSTINE AND THERAPEUTIC USE THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.6.2011EP published:
26.10.2022EP application number:
11727917.4
EPO information:
European Patent Register
Max expiry date:
31.5.2031
Title in English:
ORAL DOSAGE FORMS OF BENDAMUSTINE AND THERAPEUTIC USE THEREOFLanguage of the patent:
English
Timeline
Today
1.6.2011EP application
26.10.2022EP Publication
Owner
Name:
Pharma& Schweiz GmbHAddress:
Riedstrasse 1, 6330 Cham, CH
Inventor
Name:
PATZAK, UlrichAddress:
2300 AH Leiden, NL
Name:
OUATAS, TaoufikAddress:
2300 AH Leiden, NL
Priority
Number:
11075046Date:
14.3.2011Country:
EP
Number:
10005762Date:
2.6.2010Country:
EP
Classification
Categories:
A61K 9/48, A61K 9/14, A61K 31/4184, A61K 47/10, A61K 9/16, A61K 9/20, A61K 9/28, A61K 31/573, A61P 35/00, A61P 35/02